About bsbh

This author has not yet filled in any details.
So far bsbh has created 112 blog entries.

Gabriele Proetzel

Gabriele Proetzel, Ph.D. Director, Regenerative Medicine, Takeda Gabriele Proetzel, PhD is Director of Regenerative Medicine at Takeda Pharmaceuticals, based in Cambridge, MA. In her current role she is focused on cell and gene therapy therapeutic approaches and strategic alliance management. Prior industry appointments were Chief Scientific Officer at Scil Proteins, Halle Germany, [...]

Gabriele Proetzel 2017-10-12T07:10:48+00:00

Christian Schneider

Dr Christian K Schneider Director of National Institute for Biological Standards and Control (NIBSC) Dr Christian Schneider joined the National Institute for Biological Standards and Control (NIBSC) in January 2016, taking over as Director in April 2016. NIBSC is a centre of the Medicines and Healthcare products Regulatory Agency (MHRA). Christian is [...]

Christian Schneider 2017-10-11T15:12:58+00:00

Lord James O’Shaughnessy

Lord James O'Shaughnessy Parliamentary Under Secretary of State for Health (Lords), UK Government   Lord O’Shaughnessy was appointed as a Parliamentary Under Secretary of State at the Department of Health and a Government Whip (Lord in Waiting) in December 2016. Lord O’Shaughnessy was a senior fellow at the Legatum Institute and at [...]

Lord James O’Shaughnessy 2017-10-11T11:11:06+00:00

Karen Hodgkin

Karen Hodgkin COO, Chief Operating Officer, Cell Medica Karen has over 30 years of experience in planning and running clinical trials, which has been invaluable in the creation of Cell Medica’s highly-efficient clinical operations and regulatory function. After working as SVP, Clinical Operations, Karen has moved to become Cell Medica’s COO in [...]

Karen Hodgkin 2017-09-25T10:52:37+00:00

Peter Goodfellow

Professor Peter Goodfellow FMedSci FRS, Scientific Advisor, Abingworth Peter Goodfellow is a geneticist who tracked down the genetic essence of human ‘maleness’. In a high-profile scientific race to find the enigmatic ‘testis-determining factor’ (TDF; also known as sex-determining region Y (SRY) protein), Peter overturned others’ claims by correctly pinpointing the tiny SRY [...]

Peter Goodfellow 2017-09-25T10:50:23+00:00

Michael Stein

Dr Michael Stein, Chairman and CEO Oxstem Ltd.   Dr Michael Stein is a successful healthcare entrepreneur with a background in medical science. In 2001, he co-founded the Map of Medicine Ltd (“the Map”) with University College London. The Map was nationally licensed across NHS England in 2005 and is primarily used [...]

Michael Stein 2017-09-07T15:24:10+00:00

Ian Campbell

Ian Campbell Director for Health and Life Sciences, Innovate UK Dr Ian Campbell is an experienced executive in the life sciences. Ian joined Innovate UK in October 2016 as Director for Health and Life Sciences. Prior to that, he most recently served as Chief Executive of Arquer Diagnostics, a company developing and commercialising immunoassay [...]

Ian Campbell 2017-08-23T07:57:52+00:00

Karen Aiach

Karen Aiach Founder, Chief Executive Officer, Lysogene   Founder and CEO of Lysogene, Ms. Aiach is also the mother of a child with MPS IIIA. She has a strong business background starting her career with Arthur Andersen specializing in audit and transaction services. Her entrepreneurial experience includes founding and running a financial business consultancy. [...]

Karen Aiach 2017-08-10T13:01:53+00:00

Steve Bates

Steve Bates CEO, BioIndustry Association (BIA)   Since his appointment as Chief Executive of the Bioindustry Association in 2012, Steve Bates has led major BIA campaigns for, amongst other things, improved access to finance, the refilling of the Biomedical Catalyst, anti-microbial resistance and the opportunity the sector presents to generalist long term [...]

Steve Bates 2017-08-10T07:45:56+00:00

Adrien Lemoine

Adrien Lemoine VP Business Development & Operations, Orchard Therapeutics Adrien is currently VP Business Development & Operations at Orchard Therapeutics. He was previously Executive Director, Corporate Strategy and Development at AstraZeneca and a member of the Board of Directors of Corvidia Therapeutics. Prior to AstraZeneca, Adrien spent 9 years at GSK and [...]

Adrien Lemoine 2017-08-10T07:47:55+00:00